POST LIVER TRANSPLANT INFECTIONS — EXPERIENCE AT A TERTIARY CARE TEACHING HOSPITAL
-
Published:2022-11-01
Issue:
Volume:
Page:59-62
-
ISSN:
-
Container-title:INDIAN JOURNAL OF APPLIED RESEARCH
-
language:en
-
Short-container-title:IJAR
Author:
Muniappan Meena1, Sankar Pavithra2, Rupert Secunda3, Govindaraj Karthick4, Sathyanesan Jeswanth5, Vennila Rosy6, Rajagopal Surendran7
Affiliation:
1. Government Stanley Medical College & Hospital (Post Graduate) Chennai, Tamil Nadu, India. 2. Institute of Surgical Gastroenterology and Liver Transplant (Research Fellow), Government Stanley Medical College & Hospital, Chennai, Tamil Nadu, India 3. Government Stanley Medical College & Hospital (Senior Assistant Professor) Chennai, Tamil Nadu, India 4. Institute of Surgical Gastroenterology and Liver Transplant (Research Assiatant), Government Stanley Medical College & Hospital, Chennai, Tamil Nadu, India. 5. Institute of Surgical Gastroenterology and Liver Transplant (Director & Head), Government Stanley Medical College & Hospital, Chennai, Tamil Nadu, India 6. Institute of Surgical Gastroenterology and Liver Transplant (Professor of Microbiology) Government Stanley Medical College & Hospital, Chennai, Tamil Nadu, India. 7. Department of Hepato – Pacncreato - Billiary centre for Surgery and Transplantation (Director) MIOT international Hospital, Manapakkam, Chennai, Tamil Nadu, India
Abstract
Background: Liver Transplantation (LT) is a standard treatment option for End-stage Liver Disease (ESLD). However,
Post liver transplant infections remains a major concern. This study aimed to identify the most common microorganisms
that cause such infections in a tertiary care Hospital. A total of 30 pa Methods: tients who had undergone LT during the period (2016-2017) was
observed. The pre-transplant and post-transplant clinical samples were analysed for the presence of infectious organisms. Additionally, complete
blood investigations along with chemiluminescent microparticle immunoassay (CMIA) were performed to estimate the levels of immunemodulatory agents. The recipients did not have any infections at the time of t Results: ransplant and were followed-up for infections following
LT. Bacterial infections such as Urinary Tract Infection (UTI) (8; 26.6%), bacterial-pneumonia (4; 13.3%), surgical site infections (SSI) (4;
13.3%), and Central-venous-catheter related blood stream infections (8; 26.6%) was observed. The common gram-negative organisms such as
Escherichia coli, Klebsiella pneumoniae and gram-positive organism such as Enterococcus species and methicillin-resistant Staphylococcus
aureus (MRSA) were observed in postoperative period. Moreover, 4 patients were found to have UTI and SSI caused by fungal species such as
Candida albicans and Aspergillus species respectively. Viral infection was observed in two patients, which was due to Epstein-Barr virus, a
common virus associated with post-transplant lymphoproliferative disease (PTLD). Acute graft rejection (6; 20%) was observed and they were
treated with high doses of intravenous corticosteroids. Infections after LT is t Conclusion: he major cause of morbidity and mortality. A better
understanding of the common causative infectious organisms and early initiation of therapy may improve the survival rate of recipients.
Publisher
World Wide Journals
Subject
Statistics, Probability and Uncertainty,Business and International Management,General Computer Science,Geology,Cardiology and Cardiovascular Medicine,General Medicine,General Materials Science,Hepatology,Sociology and Political Science,History,Cultural Studies,Law,Sociology and Political Science,Immunology,General Medicine,Immunology and Allergy,Pharmacology,Immunology,Immunology and Allergy,Sociology and Political Science,Anthropology,Cultural Studies
Reference22 articles.
1. WHO|GHO data repository. http://apps.who.int/gho/data/ view.main.53420 2. Mansard, M., Siddachari, R., Kumar, G., Subramanian, N. and Olithselvan, A. (2020). Liver Transplantation Program in India: The Core-Satellites Model. Tropical Gastroenterology, 41(2), 54-59. 3. Tasdogan, B.E., Ma, M., Simsek, C., Saberi, B. and Gurakar, A. (2019). Update on Immunosuppression in Liver Transplantation. Euroasian J Hepatogastroenterol, 9(2), 96-101. doi: 10.5005/jp-journals-10018-1301. 4. Choudhary, N.S., Saigal, S., Shukla, R., Kotecha, H., Saraf, N. and Soin, A.S. (2013) Current status of immunosuppression in liver transplantation. J Clin Exp Hepatol, 3(2), 150-8. doi: 10.1016/j.jceh.2013.04.005. 5. Ayvazoglu Soy, E.H., Akdur, A., Yildirim, S., Arslan, H. and Haberal, M. (2018). Early Postoperative Infections After Liver Transplant. Exp Clin Transplant, 16, 145-148. doi: 10.6002/ect.TOND-TDTD2017.
|
|